HOOK

2.02

5.61% -0.12

Dopo l'orario di chiusura: 2.00 -0.02 -0.99%

Hookipa Pharma Inc (HOOK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.14

Aprire:

$2.08

Volume 24 ore:

73,274

Relative Volume:

1.43

Capitalizzazione di mercato:

$24.35M

Reddito:

$52.16M

Utile/perdita netta:

$-48.60M

Rapporto P/E:

-2.2198

EPS:

-0.91

Flusso di cassa netto:

$-77.48M

1 W Prestazione:

-5.16%

1M Prestazione:

-25.74%

6M Prestazione:

-69.25%

1 anno Prestazione:

-64.25%

Intervallo 1D:

$2.00

$2.14

Intervallo di 1 settimana:

$1.9601

$2.27

Portata 52W:

$1.88

$11.30

Hookipa Pharma Inc Stock (HOOK) Company Profile

Nome

Hookipa Pharma Inc

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

0114318906360

Indirizzo

350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY

Dipendente

124

Cinguettio

@HookipaPharma

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

HOOK's Discussions on Twitter

Confronta HOOK con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HOOK Hookipa Pharma Inc	2.02	24.35M	52.16M	-48.60M	-77.48M	-4.32
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-15	Reiterato	RBC Capital Mkts	Outperform
2022-12-02	Downgrade	BofA Securities	Buy → Underperform
2021-11-12	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-04-08	Iniziato	Morgan Stanley	Overweight
2020-11-03	Iniziato	Truist	Buy
2020-10-26	Iniziato	JMP Securities	Mkt Outperform
2020-10-19	Ripresa	H.C. Wainwright	Buy
2019-09-27	Iniziato	H.C. Wainwright	Buy
2019-05-13	Iniziato	BofA/Merrill	Buy
2019-05-13	Iniziato	RBC Capital Mkts	Outperform

Mostra tutto

Hookipa Pharma Inc Borsa (HOOK) Ultime notizie

Dec 21, 2024

The Market Doesn't Like What It Sees From HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) Revenues Yet As Shares Tumble 26% - Simply Wall St

Dec 21, 2024

Dec 20, 2024

RBC downgrades HOOKIPA Pharma stock to Sector Perform as restructuring resets pipeline to preclinical - Investing.com

Dec 20, 2024

Dec 16, 2024

HOOKIPA Pharma's SWOT analysis: stock faces challenges amid pipeline shifts By Investing.com - Investing.com South Africa

Dec 16, 2024

Fmr LLC Has $1.47 Million Holdings in Hookipa Pharma Inc (NASDAQ:HOOK) - Defense World

Dec 16, 2024

Dec 15, 2024

HOOKIPA Pharma's SWOT analysis: stock faces challenges amid pipeline shifts - Investing.com

Dec 15, 2024

Dec 13, 2024

Hookipa Pharma stock hits 52-week low at $2.07 amid market challenges - Investing.com

Dec 13, 2024

Dec 04, 2024

JMP Securities Has Lowered Expectations for Hookipa Pharma (NASDAQ:HOOK) Stock Price - Defense World

Nov 25, 2024

Nov 22, 2024

Hookipa Pharma price target lowered to $7 from $24 at JMP Securities - Yahoo Finance

Nov 22, 2024

Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program - Yahoo Finance

Nov 22, 2024

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges - Investing.com Canada

Nov 22, 2024

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 19, 2024

Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky - Simply Wall St

Nov 19, 2024

Nov 17, 2024

HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 17, 2024

Nov 15, 2024

HOOKIPA Pharma stock target lowered, maintains outlook on strategic direction - Investing.com

Nov 15, 2024

RBC Capital Mkts reiterated coverage on HOOKIPA Pharma with a new price target - Quantisnow

Nov 15, 2024